Heber-Katz Ellen
Laboratory of Regenerative Medicine, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.
Trends Mol Med. 2017 Nov;23(11):1024-1036. doi: 10.1016/j.molmed.2017.08.008. Epub 2017 Oct 5.
The discovery that the Murphy Roths Large (MRL) mouse strain is a fully competent, epimorphic tissue regenerator, proved that the machinery of regeneration was preserved through evolution from hydra, to salamanders, to mammals. Such concepts have allowed translation of the biology of amphibians, and their ability to regenerate, to a mammalian context. We identified the ancient hypoxia-inducible factor (HIF)-1α pathway, operating through prolyl hydroxylase domain proteins (PHDs), as a central player in mouse regeneration. Thus, the possibility of targeting PHDs or other HIF-1α modifiers to effectively recreate the amphibian regenerative state has emerged. We posit that these regenerative pathways are critical in mammals. Moreover, the current approved use of PHD inhibitors in the clinic should allow fast-track translation from mouse studies to drug-based regenerative therapy in humans.
墨菲罗斯大(MRL)小鼠品系是一种完全具备再生能力的、能够进行表观形态组织再生的动物,这一发现证明了从水螅到蝾螈再到哺乳动物的进化过程中,再生机制得以保留。这些概念使得两栖动物的生物学特性及其再生能力能够应用于哺乳动物研究中。我们发现古老的缺氧诱导因子(HIF)-1α信号通路通过脯氨酰羟化酶结构域蛋白(PHD)发挥作用,是小鼠再生过程中的关键因素。因此,通过靶向PHD或其他HIF-1α调节剂来有效重现两栖动物再生状态的可能性已经出现。我们认为这些再生途径在哺乳动物中至关重要。此外,目前临床上已批准使用PHD抑制剂,这应该能够加快从小鼠研究到基于药物的人类再生治疗的转化。